Bioindustry Ethics by David L. Finegold

Bioindustry Ethics

byDavid L. Finegold, Cecile M Bensimon, Abdallah S. Daar

Paperback | June 10, 2005

not yet rated|write a review

Pricing and Purchase Info

$73.42 online 
$86.57 list price save 15%
Earn 367 plum® points

In stock online

Ships free on orders over $25

Not available in stores

about

This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. Topics covered in this comprehensive survey include considerations for bioprospecting in transgenics, genomics, drug discovery, and nutrigenomics, as well as how to improve stakeholder relations, design ethical clinical trials, avoid conflicts of interest, and establish ethics advisory boards. The expert authors represent multiple disciplines including law, medicine, bioinformatics, pharmaceutics, business, and ethics.

Details & Specs

Title:Bioindustry EthicsFormat:PaperbackDimensions:384 pages, 9 × 6 × 0.68 inPublished:June 10, 2005Publisher:Academic PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0123693705

ISBN - 13:9780123693709

Look for similar items by category:

Customer Reviews of Bioindustry Ethics

Reviews

Extra Content

Table of Contents

Chapter 1: INTRODUCTION

Chapter 2: MERCK: STAYING THE COURSE

Chapter 3: GENZYME: PUTTING PATIENTS FIRST

Chapter 4: MILLENNIUM PHARMACEUTICALS, INC.: CREATING AND SUSTAINING CORPORATE VALUES

Chapter 5: MAXIM PHARMACEUTICALS (A): INTERNAL AND EXTERNAL DIALOGUES

Chapter 6: DIVERSA INC.: ETHICAL ISSUES IN BIOPROSPECTING PARTNERSHIPS

Chapter 7: PIPELINE BIOTECH A/S: COMPETING REGULATORY REGIMES FOR LABORATORY ANIMAL EXPERIMENTS

Chapter 8: TGN BIOTECH: A START-UP WITH ETHICAL ROOTS

Chapter 9: INTERLEUKIN GENETICS AND ALTICOR: AN UNLIKELY PARTNERSHIP

Chapter 10: SCIONA LTD.: A PIONEER IN NUTRIGENOMICS: THE PATH TO CONSUMER ACCEPTANCE

Chapter 11: AFFYMETRIX, INC.: USING CORPORATE ETHICS ADVICE

Chapter 12: PHARMASNPS INC.: CREATING AN ETHICS ADVISORY BOARD

Chapter 13: MONSANTO COMPANY: BIO-AGRICULTURE PIONEER

Chapter 14: NOVO NORDISK: THE TRIPLE BOTTOM LINE

Chapter 15: CONCLUSION: LESSONS FOR COMPANIES AND FUTURE ISSUES

INDEX

Editorial Reviews

"...lend[s] important insights to other executives and professionals who might be developing their own practices and policies."
- GENOMICS & PROTEOMICS (August 2005)